Atropine Sulfate Injection USP recall in Canada: glass particulate
In plain language
This recall involves Atropine Sulfate Injection USP (10mL Prefilled Syringe) sold in Canada. It's being recalled because an affected lot may contain glass particulate. Consult your healthcare provider before discontinuing use and follow the return steps in the official notice.
What to do
- Verify if your product is affected by lot number 41152DK.
- Consult your healthcare provider prior to discontinuing use.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
ATROPINE SULFATE INJECTION USP
Lot: 41152DK
Why this matters
Presence of glass particulate
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 41152DK
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Presence of glass particulate
What should consumers do?
Verify if your product is affected by lot number 41152DK. Consult your healthcare provider prior to discontinuing use. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Presence of glass particulate
When was this product recalled?
This product was recalled on September 20, 2023.
Is the LifeShield Abboject Syringe brand affected by this recall?
Yes, LifeShield Abboject Syringe products are affected by this recall. This recall involves Atropine Sulfate Injection USP (10mL Prefilled Syringe) sold in Canada. It's being recalled because an affected lot may contain glass particulate. Consult your healthcare provider before discontinuing use and follow the return steps in the official notice.